In an orthotopic lung cancer mouse model, intranasal S100A8 delivery effectively delayed tumor growth and prolonged survival by inducing the antioxidant activity of many key genes and activating immune cells to positively modify the immune microenvironment (Wong et al., 2022). The gene discussed is S100A8; the disease is lung carcinoma.